How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer

Read the original at CBS News ↗
Cite

Intarasuwan, K. (2026, August 20). How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer. CBS News. https://www.cbsnews.com/news/moderna-melanoma-vaccine-cancer-trial/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

CBS News · collected 2026-08-20 · by Kiki Intarasuwan

Quick Summary

Moderna is announcing a breakthrough in its mRNA vaccine trial for melanoma, a type of skin cancer. According to the results from a Phase 3 clinical trial involving over 1,100 people, the vaccine showed "statistically significant and clinically meaningful improvement" in helping patients remain cancer-free for longer. The trial used a combination of Moderna's mRNA vaccine and Merck's Keytruda drug, with results indicating that patients who received the vaccine stayed cancer-free longer than those who did not. This breakthrough has caused Moderna's stock to more than double, but it is also a significant step forward in the fight against melanoma, which affects about 112,000 people in the US each year and kills around 8,500 annually.
Written locally by qwen2.5:14b on 2026-08-20, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

Moderna, a biotech company, has announced promising results from a Phase 3 trial of its mRNA vaccine for treating melanoma, the deadliest form of skin cancer. The trial involved over 1,100 patients whose melanoma had progressed to advanced stages. According to the company, the vaccine showed significant improvement in keeping patients cancer-free for longer periods. This breakthrough is seen as a "landmark moment" for mRNA vaccines against cancer, and Moderna's stock price surged more than double on Wednesday morning following the announcement. The vaccine works by delivering synthetic mRNA into cells that targets specific mutations present in the patient's tumor, using artificial intelligence to identify which mutations to target. If approved, this vaccine could potentially prevent melanoma from returning or spreading in patients who have undergone treatment.

Written for “Moderna's Melanoma Vaccine Trials” on 2026-10-16, grounded in this article and the 1 other(s) covering the same event.

Story

📰 Moderna's Melanoma Vaccine Trials
Health · 2 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads unscored and hedges 5% of its claims. Each row says how that neighbour differs.
CBS News
⚖️ leaning not scored 🔴 50% hedged 1 of 2 📰 publisher trust 66
“Both articles report on the same Moderna melanoma vaccine trial results announced on the same day.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
21
sentences that state something as happening or true
Uncertain
5%
1 of 21 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
CBS News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-08-20 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBS News · 3039 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Kiki Intarasuwan
11 article(s) here · 1 carrying a prediction
🔮 Musgraves sang "I Will Always Love You," a song Parton released in 1974 that took on a second life when it was later recorded by the late Whitney Houston.
🔮 Starting Tuesday, Sept. 22, bear lovers will get to vote on their favorite contenders and choose which bear has packed on more pounds for the winter season.
🔮 "This is a developing situation, and we will update the public when more information becomes available," the spokesperson said.
🔮 In a Truth Social post, Mr. Trump called fears around AI possibly becoming a superintelligence that could pose a threat to human existence a hoax.
🔮 Outstanding comedy series - "Widow's Bay" (Apple TV) — Winner - "Abbott Elementary" (ABC) - "The Bear" (FX) - "Hacks" (HBO Max) - "Margo's Got Money Troubles" (Apple TV) - "Nobody Wants This" (Netflix) - "Only Murders in the Building" (Hulu) - "Shrinking" (Apple TV) Outstanding movie - "Remarkably Bright Creatures" (Netflix) — Winner - "Miss You, Love You" (Netflix) - "People We Meet on Vacation" (Netflix) - "Tom Clancy's Jack Ryan: Ghost War" (Amazon Prime Video) - "Heads of State" (Amazon Prime Video) Outstanding drama series - "The Pitt" (HBO Max) — Winner - "The Diplomat" (Netflix) - "Pluribus" (Apple TV) - "A Knight of the Seven Kingdoms" (HBO Max) - "The Gilded Age" (HBO Max) - "Paradise" (Hulu) - "Your Friends and Neighbors" (Apple TV) - "Slow Horses" (Apple TV) Outstanding limited or anthology series - "DTF St. Louis" (HBO Max) — Winner - "All Her Fault" (Peacock) - "The Beast in Me" (Netflix) - "Beef" (Netflix) - "Love Story: John F. Kennedy Jr. & Carolyn Bessette" (FX/Hulu) Outstanding writing for a drama series - "Pluribus," Vince Gilligan ("We is Us") — Winner - "The Pitt," Kirsten Pierre-Geyfman and R. Scott Gemmill ("1:00 P.M.") - "The Diplomat," Peter Ackerman and Debora Cahn ("Amagansett") - "The Pitt," Valerie Chu ("12:00 P.M.") - "Slow Horses," Will Smith ("Scars") - "Task," Brad Ingelsby ("A Still Small Voice") Outstanding directing for a comedy series - "Widow's Bay," Hiro Murai ("Welcome To Widow's Bay!") — Winner - "Abbott Elementary," Randall Einhorn ("Ballgame") - "The Bear," Christopher Storer ("Bears") - "The Chair Company," Andrew DeYoung ("Life Goes By Too F**king Fast, It Really Does.") - "Hacks," Lucia Aniello ("Hacks [Finale]") - "The Ms. Pat Show," Mary Lou Belli ("Give It Arrest") Outstanding variety series - "The Late Show with Stephen Colbert" (CBS) — Winner - "The Daily Show" (Comedy Central) - "Jimmy Kimmel Live!" (ABC) - "Last Week Tonight with John Oliver" (HBO Max) - "Saturday Night Live" (NBC) Outstanding directing for a drama series - "Slow Horses," Saul Metzstein ("Scars") — Winner - "The Gilded Age," Salli Richardson Whitfield ("My Mind Is Made Up") - "The Pitt," Noah Wyle ("12:00 P.M.") - "Paradise," Hanelle M. Culpepper ("Exodus") - "Pluribus," Vince Gilligan ("We is Us") - "Task," Salli Richardson Whitfield ("Out Beyond Ideas Of Wrongdoing And Rightdoing, There Is A River.") Outstanding writing for a comedy series - "Widow's Bay," Katie Dippold ("Welcome To Widow's Bay!") — Winner - "Abbott Elementary," Quinta Brunson ("Team Building") - "The Chair Company," Tim Robinson and Zach Kanin ("Life Goes By Too F**king Fast, It Really Does.") - "The Comeback," Michael Patrick King and Lisa Kudrow ("Valerie Does It All") - "Hacks," Lucia Aniello, Paul W. Downs and Jen Statsky ("Hacks [Finale]") - "Jury Duty Presents Company Retreat," Anthony King ("Mergers And Acquisitions") Outstanding lead actor in a comedy series - Matthew Rhys, "Widow's Bay" — Winner - Yahya Abdul-Mateen II, "Wonder Man" - Steve Carell, "Rooster" - Jason Segel, "Shrinking" - Martin Short, "Only Murders in the Building" Outstanding lead actress in a limited or anthology series or movie - Sally Field, "Remarkably Bright Creatures" — Winner - Claire Danes, "The Beast in Me" - Carey Mulligan, "Beef" - Sarah Pidgeon, "Love Story: John F. Kennedy Jr. & Carolyn Bessette" - Sarah Snook, "All Her Fault" Outstanding supporting actor in a drama series - Tom Pelphrey, "Task" — Winner - Patrick Ball, "The Pitt" - Billy Crudup, "The Morning Show" - Shawn Hatosy, "The Pitt" - Gerran Howell, "The Pitt" - Jack Lowden, "Slow Horses" - Carlos-Manuel Vesga, "Pluribus" Outstanding lead actor in a drama series - Noah Wyle, "The Pitt" — Winner - Sterling K. Brown, "Paradise" - Gary Oldman, "Slow Horses" - Mark Ruffalo, "Task" - Rufus Sewell, "The Diplomat" Outstanding reality competition program - "The Traitors" (Peacock) — Winner - "Dancing with the Stars" (ABC) - "RuPaul's Drag Race" (MTV) - "Survivor" (CBS) - "Top Chef" (Bravo) Outstanding supporting actor in a comedy series - Stephen Root, "Widow's Bay" — Winner - Colman Domingo, "The Four Seasons" - Paul W. Downs, "Hacks" - Harrison Ford, "Shrinking" - Nick Offerman, "Margo's Got Money Troubles" - Michael Urie, "Shrinking" - Tyler James Williams, "Abbott Elementary" Outstanding lead actress in a drama series - Rhea Seehorn, "Pluribus" — Winner - Carrie Coon, "The Gilded Age" - Chase Infiniti, "The Testaments" - Keri Russell, "The Diplomat" - Zendaya, "Euphoria" Outstanding supporting actress in a drama series - Allison Janney, "The Diplomat" — Winner - Taylor Dearden, "The Pitt" - Fiona Dourif, "The Pitt" - Katherine LaNasa, "The Pitt" - Sepideh Moafi, "The Pitt" - Julianne Nicholson, "Paradise" - Karolina Wydra, "Pluribus" Outstanding lead actor in a limited or anthology series or movie - Matthew Rhys, "The Beast in Me" — Winner - Riz Ahmed, "Bait" - Jason Bateman, "Black Rabbit" - Charlie Hunnam, "Monster: The Ed Gein Story" - Oscar Isaac, "Beef" Outstanding lead actress in a comedy series - Jean Smart, "Hacks" — Winner - Quinta Brunson, "Abbott Elementary" - Ayo Edebiri, "The Bear" - Elle Fanning, "Margo's Got Money Troubles" - Lisa Kudrow, "The Comeback" Outstanding supporting actress in a comedy series - Kate O'Flynn, "Widow's Bay" — Winner - Dale Dickey, "Widow's Bay" - Hannah Einbinder, "Hacks" - Janelle James, "Abbott Elementary" - Michelle Pfeiffer, "Margo's Got Money Troubles" - Megan Stalter, "Hacks" - Jessica Williams, "Shrinking"
2026-09-15 · assertive framing · Who won Emmys for 2026? See the full winners list here.
🔮 "Grand Canyon National Park staff, in coordination with the Arizona Department of Public Safety, are continuing evacuation and response efforts and working to account for individuals who may have been in the affected area," NPS said in a statement.
🔮 I will always love her in the same way ….. with my whole heart … and I always will," he added.
🔮 Moderna is touting a "landmark moment" in its , saying its vaccine could help prevent the deadly skin cancer from returning or spreading.
Also by Kiki Intarasuwan
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 11 articles by Kiki Intarasuwan →

Topics

CBS News Food and Drug Administration Keytruda Merck Moderna

Subjects

Moderna ORG · 6× LaPook ORG · 3× CBS News ORG · 2× Merck ORG · 2× Céline Gounder PERSON · 1× Food and Drug Administration ORG · 1× Gounder PERSON · 1× Jon LaPook PERSON · 1× U.S. GPE · 1× the United States GPE · 1×

Narrative

For patients whose melanoma had gone deeper, or reached the lymph nodes, Moderna and its drug development partner Merck said the novel treatment showed "statistically significant and clinically meaningful improvement" in helping patients remain cancer-free for longer.
framing: assertive · carried by 1 article(s) · first seen 2026-08-20
🔮 Moderna is touting a "landmark moment" in its , saying its vaccine could help prevent the deadly skin cancer from returning or spreading.
2026-08-20 · CBS News
How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer · assertive framing

Claims (21 extracted, 1 hedged)

Moderna is touting a "landmark moment" in its , saying its vaccine could help prevent the deadly skin cancer from returning or spreading. uncertain
vaccine → tout → cancer
The groundbreaking clinical trial studied over 1,100 people whose melanoma was in advanced stages, taking a piece of a patient's tumor and using it to build a shot, CBS News medical correspondent Dr. Céline Gounder explained. asserted
Gounder → study → shot
The results came from a Phase 3 trial, the last stage before a Food and Drug Administration review. asserted
results → come → review
Gounder, who has had melanoma herself but noticed it very early, said the trial is "a big win for mRNA vaccines against cancer." asserted
trial → have → cancer
Following the news, Moderna's stock more than doubled on Wednesday morning. asserted
stock → follow → morning
Here's what to know about the melanoma vaccine: How does the melanoma vaccine work? asserted
vaccine → know → vaccine
After a piece of the patient's tumor is removed, it is analyzed to identify the unique mutations present, CBS News chief medical correspondent Dr. Jon LaPook said. asserted
LaPook → remove → mutations
Artificial intelligence is then used to help scientists figure out which of the hundreds of mutations should be included in the vaccine. asserted
which → use → vaccine
Like other mRNA vaccines, Moderna's melanoma vaccine delivers synthetic mRNA into cells, delivering a "one-two punch" to melanoma, LaPook said. asserted
LaPook → deliver → melanoma
Moderna's mRNA vaccine — used in combination with Merck's cancer immunotherapy drug Keytruda — is built from a patient's own tumor, which has its own genetic sequence, so each dose is personalized. asserted
dose → use → sequence
"Cancer can put a cloak of invisibility around itself so the immune system can't see it, and the first punch is a drug called Keytruda, which removes the cloak," LaPook explained. asserted
LaPook → put → cloak
Meanwhile, the patient's cells read the mRNA and build a protein, breaking the messenger down. asserted
cells → read → messenger
That protein then trains the immune system to learn to attack cancer cells. asserted
system → train → cells
The vaccine gives the immune system the scent of melanoma so the immune system can hunt it down and kill it," LaPook said. asserted
LaPook → give → it
What did Moderna's melanoma vaccine trial find? asserted
trial → find → What
For patients whose melanoma had gone deeper, or reached the lymph nodes, Moderna and its drug development partner Merck said the novel treatment showed "statistically significant and clinically meaningful improvement" in helping patients remain cancer-free for longer. asserted
patients → go → improvement
For those participating in the trial, surgeons had already removed their tumors, and everyone had been treated with Keytruda, the standard immunotherapy. asserted
everyone → participate → Keytruda
But some patients were also given the mRNA melanoma vaccine. asserted
patients → give → vaccine
That group stayed cancer-free longer, the trial found. asserted
trial → stay → ?
about 8,500 people in the U.S. will die from melanoma this year. is the fifth most commonly diagnosed cancer in the United States, with about 112,000 new cases each year. asserted
people → die → cases
The American Cancer Society projects that asserted
Society → project → ?
💬Give feedback
🕘History 🎫Support